Filing Details
- Accession Number:
- 0001396814-25-000069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-05 17:40:22
- Reporting Period:
- 2025-06-03
- Filing Date:
- 2025-06-05
- Accepted Time:
- 2025-06-05 17:40:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1396814 | Pacira Biosciences Inc. | PCRX | Pharmaceutical Preparations (2834) | 510619477 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1545439 | Lauren Riker | C/O Pacira Biosciences, Inc. 2000 Sierra Point Parkway, Suite 900 Brisbane CA 94005 | Senior Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-06-03 | 3,374 | $26.40 | 65,142 | No | 4 | F | Direct | |
Common Stock | Disposition | 2025-06-04 | 5,578 | $26.21 | 59,564 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.15 to $26.38, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2.